251 related articles for article (PubMed ID: 17414011)
1. Use of a dynamic foot pressure index to monitor the effects of treatment for equinus gait in children with cerebral palsy.
Bennett D; Walsh M; O'Sullivan R; Gallagher J; O'Brien T; Newman CJ
J Pediatr Orthop; 2007; 27(3):288-94. PubMed ID: 17414011
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
3. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response.
Sätilä H; Huhtala H
Am J Phys Med Rehabil; 2010 Nov; 89(11):865-72. PubMed ID: 20736816
[TBL] [Abstract][Full Text] [Related]
6. Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy.
Zürcher AW; Molenaers G; Desloovere K; Fabry G
Acta Orthop Belg; 2001 Dec; 67(5):475-80. PubMed ID: 11822078
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
[TBL] [Abstract][Full Text] [Related]
8. Automated feature assessment in instrumented gait analysis.
Wolf S; Loose T; Schablowski M; Döderlein L; Rupp R; Gerner HJ; Bretthauer G; Mikut R
Gait Posture; 2006 Apr; 23(3):331-8. PubMed ID: 15955701
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
[TBL] [Abstract][Full Text] [Related]
10. Treatment of spastic equinus gait with botulinum toxin A: Does dose matter? Analysis of a clinical cohort.
Sätilä HK; Pietikäinen T; Lehtonen-Räty P; Koivikko M; Autti-Rämö I
Neuropediatrics; 2006 Dec; 37(6):344-9. PubMed ID: 17357036
[TBL] [Abstract][Full Text] [Related]
11. [Does footprint and foot progression matter for ankle power generation in spastic hemiplegic cerebral palsy?].
Riad J; Henley J; Miller F
Acta Orthop Traumatol Turc; 2009; 43(2):128-34. PubMed ID: 19448353
[TBL] [Abstract][Full Text] [Related]
12. Gastrocnemius and soleus lengths in cerebral palsy equinus gait--differences between children with and without static contracture and effects of gastrocnemius recession.
Wren TA; Do KP; Kay RM
J Biomech; 2004 Sep; 37(9):1321-7. PubMed ID: 15275839
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint.
Galli M; Crivellini M; Santambrogio GC; Fazzi E; Motta F
Funct Neurol; 2001; 16(4):317-23. PubMed ID: 11853322
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.
Corry IS; Cosgrove AP; Duffy CM; McNeill S; Taylor TC; Graham HK
J Pediatr Orthop; 1998; 18(3):304-11. PubMed ID: 9600553
[TBL] [Abstract][Full Text] [Related]
16. Influence of equinus treatments on the vertical displacement of the body's centre of mass in children with cerebral palsy.
Massaad F; van den Hecke A; Renders A; Detrembleur C
Dev Med Child Neurol; 2006 Oct; 48(10):813-8. PubMed ID: 16978460
[TBL] [Abstract][Full Text] [Related]
17. Dynamic foot pressure measurements for assessing foot deformity in persons with spastic cerebral palsy.
Park ES; Kim HW; Park CI; Rha DW; Park CW
Arch Phys Med Rehabil; 2006 May; 87(5):703-9. PubMed ID: 16635634
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy.
Manganotti P; Zaina F; Falso M; Milanese F; Fiaschi A
J Rehabil Med; 2007 Mar; 39(2):115-20. PubMed ID: 17351692
[TBL] [Abstract][Full Text] [Related]
19. Assessment protocol for serial casting after botulinum toxin a injections to treat equinus gait.
Kelly B; MacKay-Lyons MJ; Berryman S; Hyndman J; Wood E
Pediatr Phys Ther; 2008; 20(3):233-41. PubMed ID: 18703960
[TBL] [Abstract][Full Text] [Related]
20. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
